Century Therapeutics (NASDAQ: IPSC) revenue
Century Therapeutics reported revenue of $109.2m for fiscal 2025, 1,556.8% more than in fiscal 2024 ($6.6m). Since fiscal 2022 its revenue has grown by 1,999.7%, an average growth of 175.9% a year.
Century Therapeutics has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 4 fiscal years on record. The biggest drop was in fiscal 2023, −57.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $109.2m | +1,556.8% | −$17.3m | −15.8% |
| 2024 | $6.6m | +194.8% | −$138.1m | −2,096.5% |
| 2023 | $2.2m | −57.0% | −$146.5m | −6,556.9% |
| 2022 | $5.2m | — | −$133.8m | −2,574.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Century Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, Century Therapeutics ranks 281st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Century Therapeutics, 1,556.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 279th | Anika Therapeutics | $112.8m | −5.9% |
| 280th | UroGen Pharma | $109.8m | 21.4% |
| 281st | Century Therapeutics | $109.2m | 1,556.8% |
| 282nd | Zevra Therapeutics | $106.5m | 350.9% |
| 283rd | Zymeworks | $106.0m | 38.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Century Therapeutics
- How much revenue did Century Therapeutics make in fiscal 2025?
- Century Therapeutics reported revenue of $109.2m for fiscal 2025, compared with $6.6m in fiscal 2024.
- How much has the revenue of Century Therapeutics grown?
- Between fiscal 2022 and fiscal 2025 it went from $5.2m to $109.2m: 1,999.7% more, an average growth of 175.9% a year.
- What was the best year for revenue at Century Therapeutics?
- Of its last 4 fiscal years, fiscal 2025, with $109.2m.
- Where does Century Therapeutics rank in its sector by revenue?
- It ranks 281st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Century Therapeutics come from?
- From the annual report (Form 10-K) that Century Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Century Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Century Therapeutics: the Century Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.